Pharmacology Flashcards
Pharmacokinetics
The effect of the body on the drug
ADME:
Absorption, distribution, metabolism, excretion
Pharmacodynamics
The effects of the drug on the body
Includes drug efficacy, drug potency, drug toxicity
Bioavailability (F)
Fraction of administered drug that reaches systemic circulation unchanged
For an IV dose, F = 100%
Orally F typically <100% due to incomplete absorption and first-pass metabolism
Volume of distribution Vd
Theoretical volume occupied by the total absorbed drug amount at the plasma concentration measured
Vd = amount of drug / plasma drug concentration
Low Vd: drug in Vd
Medium Vd: drug in ECF
High Vd: drug in all tissues including fat
Half life T1/2
Time required to change the amount of drug in the body by 1/2 during elimination
Property of ONLY first-order elimination
Drug infused at a constant rate takes 4-5 half lives to reach steady state
T1/2 = (0.693 x Vd) / Clearance (CL)
Clearance CL
The volume of plasma cleared of drug per unit time.
Clearance may be impaired with defects in cardiac, hepatic, or renal function
CL = rate of elimination / plasma drug concentration
Dosage calculation
Loading dose = (Cp (target concentration) x Vd ) / F
Maintenance dose = (Cp x CL x tau (dosage interval) ) / F
In renal or liver disease, maintenance dose decreases but loading dose is usually unchanged
Zero order elimination
Rate of elimination is constant regardless of drug concentration
Concentration decreases linearly w time
Ex: phenytoin, ethanol, aspirin
First order elimination
Rate of elimination is directly proportional to the drug concentration
Concentration decreases exponentially w time
Urine pH and drug elimination
Ionized species are trapped in urine and cleared quickly while neutral ones are often reabsorbed
Weak acids: aspirin, methotrexate, trapped in basic environment, add bicarb for overdose
Weak bases: amphetamines, trapped in acidic environment, add ammonium chloride for overdose
Drug metabolism
Phase I: reduction, oxidation, hydrolysis with cytochrome p450, usually yields slightly polar, water-soluble metabolites often still active
Phase II: conjugation (glucuronidation, acetylation, sulfation) usually yields very polar, inactive metabolites (renal excreted)
Geriatric patients often lose phase 1 before phase 2
Efficacy
Maximal effect a drug can produce
High efficacy drug classes are analgesic medications, antibiotics, antihistamines
Partial agonists often have less efficacy than full agonists
Potency
Amount of drug needed for a given effect
Increased potency usually means increased affinity for a certain receptor
Highly potent drugs include chemotherapeutic drugs, antihypertensives, and lipid lowering drugs
Competitive antagonist
No change in efficacy but decreases potency of original drug
Efficacy is overcomes by increasing the concentration of original agonist substrate
Noncompetitive antagonist/irreversible competitive antagonist
Decreases efficacy.
Cannot be overcome by increasing concentration of original agonist substrate
Partial agonist
Acts at the same site as full agonist, but with lower maximal efficacy.
Potency can vary compare to full agonist depending on concentration and type
Nicotinic Ach receptor
Ligand gated Na/K channels
Nn found in autonomic ganglia
Nm found in neuromuscular junction
Muscarinic Ach receptor
G protein coupled receptors that usually act through 2ndary messengers
5 subtypes: M1,2,3,45
Alpha1 receptor
Sympathetic
Increase vascular smooth muscle contraction
Increase pupillary dilator muscle contraction
Increase intestinal and blade sphincter muscle contraction
Alpha2 receptor
Sympathetic
Decrease sympathetic outflow
Decrease insulin release
Decrease lipolysis
Beta1 receptor
Sympathetic
Increase heart rate
Increase heart contractility
Increase renin release
Increase lipolysis
Beta2 receptor
Sympathetic
Vasodilation Bronchodilation Increase heart rate Increase heart contractility Increase insulin release Decrease uterine tone Increase aqueous humor production
M1
Parasympathetic
CNS
Enteric nervous system
M2
Parasympathetic
Decrease heart rate
Decrease contractility of atria